Brief Introduction:

• National Medical Insurance, Category B.

• Launched in 1999 and awarded as an excellent brand of biological and biochemical products in China's ChemPharm industry.

• National standard bulk supplier of Filgrastim. Participated in the development and collaborative calibration of Filgrastim national reference standards.

• Participated in the collaborative calibration of Filgrastim reference standard organized by USP, WHO and other international organizations.

Indications:

Neutropenia resulting from cancer chemotherapy. For details, please refer to Instructions.